The Delta variant of SARS-CoV-2 has been shown to be more transmissible than other variants of concern, however, it cannot be speculated that this variant by itself can give rise to a third wave of COVID-19 in the country, Lok Sabha was informed on Friday.
The surge in cases is also dependent on available susceptible population, including a host of pharmaceutical and non-pharmaceutical interventions like vaccination, Minister of State for Health Bharati Pravin Pawar said in a written reply.
The SARS-CoV-2 being an RNA virus is prone to mutations, the ministry said, underlining that laboratories undertake genetic analysis of circulating virus to detect such changes which develop naturally and continuously and may have significant public health implications.
The Delta variant was first detected in India on genomic sequencing of samples in October 2020. This variant is the dominant lineage for new cases across India currently and remains the most rapidly rising lineage globally.
"Delta variant of SARS-CoV-2 has been shown to be more transmissible than other variants of concern. However, it cannot be speculated that this variant by itself can give rise to third wave of COVID-19 in the country since the surge in cases is also dependent on available susceptible population including host of pharmaceutical and non-pharmaceutical interventions including vaccination," the minister said.
The government of India under the INSACOG network of laboratories is also undertaking genomic sequencing of positive samples. Information on genome sequencing for mutant variants of SARS-CoV-2 is regularly shared with the states.
The issue of mutant variants is also flagged through regular formal communications to all states and UTs.
The MoHFW has alerted all the states and UTs to keep a watch on any unusual surge in COVID-19 cases from districts in which the delta-plus variant was detected as well as from other districts.
States and UTs have been advised to keep strict surveillance in the districts reporting new variants of concern and take up stringent public health measures, Pawar said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)